十大网赌正规网址下载(2024官方网站)

Be the most trusted biotech company

2019-04-25

Henlius Trastuzumab HLX02 Filed New Drug Application
2019-04-03

Shanghai Henlius Set to Increase Awareness of Biosimilars, in Partnership with Nature Research
2019-03-22

Global Clinical Medicine Affairs Department Needs You to Join!
2019-03-19

The 2nd Combination Immunotherapy of Henlius Received Notification of Acceptance
2019-03-01

Official Announcement! Mr. WenjieZhang is Appointed as SVP and CCO of Henlius
2019-02-25

Henlius Receives NMPA Approval for Its First Product HLX01 –The Beginning of a New Era for Biosimilar
2019-02-12

New progress! Henlius HLX22 Received Clinical Approval from NMPA
2019-01-29

Henlius Completed Phase 1/2 Study of Its Rituximab Injection for Rheumatoid Arthritis
2019-01-24

Henlius Adalimumab Received Acceptance of New Drug Application

1
2
3
4